Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 69.01M
March 31, 2026 50.16M
December 31, 2025 42.21M
September 30, 2025 -10.68M
June 30, 2025 -40.54M
March 31, 2025 -31.01M
December 31, 2024 -22.10M
September 30, 2024 -26.83M
June 30, 2024 -23.95M
March 31, 2024 -25.49M
December 31, 2023 -16.19M
September 30, 2023 -12.04M
June 30, 2023 -5.807M
March 31, 2023 -8.823M
December 31, 2022 -5.094M
September 30, 2022 -5.868M
June 30, 2022 -8.436M
March 31, 2022 -9.782M
December 31, 2021 -7.579M
Date Value
September 30, 2021 -5.830M
June 30, 2021 -8.295M
March 31, 2021 -12.44M
December 31, 2020 -14.13M
September 30, 2020 -12.63M
June 30, 2020 -13.52M
March 31, 2020 -14.62M
December 31, 2019 -14.19M
September 30, 2019 -12.59M
June 30, 2019 -13.00M
March 31, 2019 -10.35M
December 31, 2018 -8.430M
September 30, 2018 -6.420M
June 30, 2018 -7.594M
March 31, 2018 -10.26M
December 31, 2017 -5.956M
September 30, 2017 -6.292M
June 30, 2017 -5.493M
March 31, 2017 -9.093M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Harmony Biosciences Holdings, Inc. 92.43M
Johnson & Johnson 7.295B
United Therapeutics Corp. 202.20M
Amneal Pharmaceuticals, Inc. -143.99M
Pfizer Inc. 302.00M